Study of Individualized Amonafide to Treat Prostate Cancer
Clinical trial NCT00087854 · COMPLETED
Trial details
- NCT number
- NCT00087854
- Sponsor
- Xanthus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2005-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.